Yumanity Therapeutics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
Yumanity Therapeutics General Information
Description
Developer of transformative brain-penetrating small molecule drugs designed for the treatment of neurodegenerative diseases caused by protein misfolding. The company is focused on the discovery and development of innovative, disease-modifying therapies for patients with Parkinson's disease and related disorders, amyotrophic lateral sclerosis and Alzheimer's disease.
Contact Information
Website
www.yumanity.comCorporate Office
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
Corporate Office
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
Yumanity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Merger/Acquisition | 16-Dec-2022 | Completed | Generating Revenue | |||
| 12. PIPE | 06-Dec-2022 | Completed | Generating Revenue | |||
| 11. PIPE | 22-Dec-2020 | Completed | Generating Revenue | |||
| 10. Reverse Merger | 22-Dec-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 24-Jun-2020 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
| 7. Mezzanine | 31-Dec-2019 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 29-Jun-2018 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 18-Feb-2016 | $51M | $51M | Completed | Startup | |
| 4. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
Yumanity Therapeutics Comparisons
Industry
Financing
Details
Yumanity Therapeutics Competitors (40)
One of Yumanity Therapeutics’s 40 competitors is Prothena, a Corporation company based in Dublin, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Prothena | Corporation | Dublin, Ireland | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| CuraSen | Venture Capital-Backed | San Carlos, CA | ||||
| Alector | Formerly VC-backed | South San Francisco, CA | ||||
| IRulya Therapeutics | Formerly VC-backed | New Haven, CT |
Yumanity Therapeutics Signals
Yumanity Therapeutics Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent AI | Corporation | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Altium Capital Management | Growth/Expansion | Minority | ||
| Biogen | Corporation | Minority | ||
| Dolby Family Ventures | Venture Capital | Minority |
Yumanity Therapeutics Acquisitions (2)
Yumanity Therapeutics’s most recent deal was a Reverse Merger with Kineta for . The deal was made on 16-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kineta | 16-Dec-2022 | Reverse Merger | Drug Discovery | ||
| Proteostasis Therapeutics | 22-Dec-2020 | Merger/Acquisition | Drug Discovery |
Yumanity Therapeutics FAQs
-
When was Yumanity Therapeutics founded?
Yumanity Therapeutics was founded in 2014.
-
Where is Yumanity Therapeutics headquartered?
Yumanity Therapeutics is headquartered in Boston, MA.
-
What is the size of Yumanity Therapeutics?
Yumanity Therapeutics has 6 total employees.
-
What industry is Yumanity Therapeutics in?
Yumanity Therapeutics’s primary industry is Drug Discovery.
-
Is Yumanity Therapeutics a private or public company?
Yumanity Therapeutics is a Private company.
-
What is Yumanity Therapeutics’s current revenue?
The current revenue for Yumanity Therapeutics is .
-
How much funding has Yumanity Therapeutics raised over time?
Yumanity Therapeutics has raised $1.45B.
-
Who are Yumanity Therapeutics’s investors?
Agent AI, Alexandria Venture Investments, Altium Capital Management, Biogen, and Dolby Family Ventures are 5 of 16 investors who have invested in Yumanity Therapeutics.
-
Who are Yumanity Therapeutics’s competitors?
Prothena, Capricor Therapeutics, CuraSen, Alector, and IRulya Therapeutics are some of the 40 competitors of Yumanity Therapeutics.
-
When was Yumanity Therapeutics acquired?
Yumanity Therapeutics was acquired on 16-Dec-2022.
-
Who acquired Yumanity Therapeutics?
Yumanity Therapeutics was acquired by Kineta.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process